Manimaran, D., Elangovan, N. and Palanisamy, V. (2024) “Anti-Tumorgenic Impact of Nano-Formulated Peptide HIF-Alpha Therapy by DMBA Induced Mammary Carcinoma in Rodent Type”, Jordan Journal of Pharmaceutical Sciences, 17(4), pp. 783–793. doi: 10.35516/jjps.v17i4.2482.